3 ms·

How is it crazy if we have CICP and HRSA already in place? The only thing that bill would achieve is that no pharmacy company would ever develop new vaccines.

sfusato 4y ago
Why wouldn't they?
- theCrowing 4y ago
  Why would they? Big pharma wants big money. Getting sued doesn't make money. Still not answering the question why we would even need it with CICP and HRSA in place.
  - sfusato 4y ago
    So, "privatize the profits, socialize the losses"?
    - theCrowing 4y ago
      Let's play a game where you answer my question and after that I will answer the next from "you". Despite that "your" new question is irrelevant if you know how CICP and HRSA are financed. Would have expected more expertise from someone who rants about vaccines for years now. yikes.
    - deleted 4y ago
      [deleted]
- jleyank 4y ago
  There’s little money in vaccines and it would not take much loss-from-use to make then a loss leader. Yeah, they’re used in bulk but nowhere as much as “proper” drugs. If the govt wants vaccines, particularly on very short notice, they have to bear the risk. Otherwise they’ll be developed on the multi year cycle of drugs and biologics. Assuming the need is large enough to bother. Edit to following reply: Abbvie make billions and billions from Humera and it’s been successful in all sorts of applications. Took new technology and several years to get to market and takes far less manufacturing and distribution costs than a worldwide vaccine. One could argue that it’s more successful in what it does vs the covid vaccines, but RA wasn’t a pressing world problem. Remember: good, fast, cheap. Pick two. Without the government payments and guarantees that cash to Pfizer would have come from something else. It’s what drug companies do. Maybe we’d have seen an mRNA based cancer treatment sooner or maybe something like diabetes. On the whole, I’ll take the haste re vaccines in the current system when facing novel viruses of unknown pathology. YMMV
  - sfusato 4y ago
    > There’s little money in vaccines "Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years." https://www.nasdaq.com/articles/pfizers-set-to-make-%24131-billion-in-covid-sales-in-2-years.-is-the-stock-a-buy https://www.nasdaq.com/articles/pfizers-set-to-make-%24131-b...
    - bediger4000 4y ago
      Lucky for Pfizer that COVID scale diseases are common, eh?
      - jleyank 4y ago
        There are larger market segments, such as Alzheimer’s, that have consumed billions of D&D dollars. So yeah, there are other ways to make $billion if the blockbusters hit. Humera as I recall was 1-2 bil/quarter back in the 00’s. Big bucks in that industry and the trend now seems to be biologics which can be tailored more specifically than small molecule drugs.

sfusato 4y ago

Why wouldn't they?

theCrowing 4y ago
Why would they? Big pharma wants big money. Getting sued doesn't make money. Still not answering the question why we would even need it with CICP and HRSA in place.
- sfusato 4y ago
  So, "privatize the profits, socialize the losses"?
  - theCrowing 4y ago
    Let's play a game where you answer my question and after that I will answer the next from "you". Despite that "your" new question is irrelevant if you know how CICP and HRSA are financed. Would have expected more expertise from someone who rants about vaccines for years now. yikes.
  - deleted 4y ago
    [deleted]
jleyank 4y ago
There’s little money in vaccines and it would not take much loss-from-use to make then a loss leader. Yeah, they’re used in bulk but nowhere as much as “proper” drugs. If the govt wants vaccines, particularly on very short notice, they have to bear the risk. Otherwise they’ll be developed on the multi year cycle of drugs and biologics. Assuming the need is large enough to bother. Edit to following reply: Abbvie make billions and billions from Humera and it’s been successful in all sorts of applications. Took new technology and several years to get to market and takes far less manufacturing and distribution costs than a worldwide vaccine. One could argue that it’s more successful in what it does vs the covid vaccines, but RA wasn’t a pressing world problem. Remember: good, fast, cheap. Pick two. Without the government payments and guarantees that cash to Pfizer would have come from something else. It’s what drug companies do. Maybe we’d have seen an mRNA based cancer treatment sooner or maybe something like diabetes. On the whole, I’ll take the haste re vaccines in the current system when facing novel viruses of unknown pathology. YMMV
- sfusato 4y ago
  > There’s little money in vaccines "Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years." https://www.nasdaq.com/articles/pfizers-set-to-make-%24131-billion-in-covid-sales-in-2-years.-is-the-stock-a-buy https://www.nasdaq.com/articles/pfizers-set-to-make-%24131-b...
  - bediger4000 4y ago
    Lucky for Pfizer that COVID scale diseases are common, eh?
    - jleyank 4y ago
      There are larger market segments, such as Alzheimer’s, that have consumed billions of D&D dollars. So yeah, there are other ways to make $billion if the blockbusters hit. Humera as I recall was 1-2 bil/quarter back in the 00’s. Big bucks in that industry and the trend now seems to be biologics which can be tailored more specifically than small molecule drugs.